which should describe the disease to be treated and how the new drug will improve disease management by either satisfying an unmet need or improving the benefit-risk profile over existing therapies.
which should describe the disease to be treated and howthe new drug will improve disease management by either satisfying an unmet need or improving the benefit-risk profile overexisting therapies.